| http://www.w3.org/ns/prov#value | - The present invention additionally encompasses kits comprising one or more biomarker polypeptides, and/or anti-biomarker antibodies, which can be used to predict the likelihood of dose-dependent peripheral edema or edema like effects, of one or more drugs, compounds, or other therapeutic agents.
|
